PATENT CLAIM ANALYSIS

Application Number: 15960709
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["424", "400000"]

Abstract:
This disclosure provides pharmaceutical adenovirus formulations, in particular, liquid pharmaceutical formulations comprising adenoviruses.

Claim (Index 21):
A method of preserving a recombinant adenovirus, the method comprising:\n a. preparing a recombinant adenovirus formulation, wherein the formulation comprises:\n i. a recombinant adenovirus; \n ii. a citrate buffer having a concentration of between about 5 mM and about 30 mM; \n iii. hydroxypropyl-beta-cyclodextrin (HBCD); \n iv. a salt; and \n v. a non-ionic detergent;\n wherein said formulation has a pH of between about 5.5 and about 6.5, and \n wherein the formulation is a liquid formulation, and \n \n b. storing said formulation at or below \u221265\u00b0 C., wherein storing the formulation at or below \u221265\u00b0 C. preserves the recombinant adenovirus.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 91.0
- Lexical Diversity: 1.23077
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14916539', '11071095', '10791503', '14988138', '14208919']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7082584316624616
- 35 USC 102 Novelty (BERT): 0.6370300607400653
- Combined Prediction Score: 0.701135594570222
- Mean Citation Score: 320.70632599999993
- Max Citation Score: 602.6609
- Similarity Product: 559.9170335912229

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test